Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome
从那他珠单抗换用抗CD20单克隆抗体:较短的过渡期与更好的疗效相关
期刊:European Journal of Neurology
影响因子:3.9
doi:10.1111/ene.16587
Bsteh, Gabriel; Hoepner, Robert; Gernert, Jonathan A; Berek, Klaus; Gradl, Christiane; Kliushnikova, Dariia; Damulina, Anna; Traxler, Gerhard; Föttinger, Fabian; Habernig, Sebastian; Krajnc, Nik; Betancourt, Alejandro Xavier León; Ponleitner, Markus; Zrzavy, Tobias; Deisenhammer, Florian; Di Pauli, Franziska; Havla, Joachim; Khalil, Michael; Kümpfel, Tania; Wipfler, Peter; Chan, Andrew; Berger, Thomas; Hammer, Helly; Hegen, Harald